These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 1697301)
41. Regulation of CAMP (cathelicidin antimicrobial peptide) expression in adipocytes by TLR 2 and 4. Höpfinger A; Karrasch T; Schäffler A; Schmid A Innate Immun; 2021 Feb; 27(2):184-191. PubMed ID: 33509002 [TBL] [Abstract][Full Text] [Related]
42. Serum Levels and Adipose Tissue Gene Expression of Cathelicidin Antimicrobial Peptide (CAMP) in Obesity and During Weight Loss. Hochberg A; Patz M; Karrasch T; Schäffler A; Schmid A Horm Metab Res; 2021 Mar; 53(3):169-177. PubMed ID: 33434932 [TBL] [Abstract][Full Text] [Related]
43. Downregulation of CTRP-3 by Weight Loss In Vivo and by Bile Acids and Incretins in Adipocytes In Vitro. Schmid A; Gehl J; Thomalla M; Hochberg A; Kreiß A; Patz M; Karrasch T; Schäffler A Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33142914 [TBL] [Abstract][Full Text] [Related]
44. Innate Immunity of Adipose Tissue in Rodent Models of Local and Systemic Schmid A; Karrasch T; Thomalla M; Schlegel J; Salzberger B; Schäffler A; Hanses F Mediators Inflamm; 2017; 2017():5315602. PubMed ID: 28428684 [No Abstract] [Full Text] [Related]
45. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Schaeffler A; Gross P; Buettner R; Bollheimer C; Buechler C; Neumeier M; Kopp A; Schoelmerich J; Falk W Immunology; 2009 Feb; 126(2):233-45. PubMed ID: 18624726 [TBL] [Abstract][Full Text] [Related]
46. Insulin but not IGF-I is required for the maintenance of the adipose phenotype in the adipogenic cell line 1246. Serrero G; Lepak N In Vitro Cell Dev Biol Anim; 1999; 35(10):642-6. PubMed ID: 10614875 [TBL] [Abstract][Full Text] [Related]
47. Analysis of the mitogenic effect of fetuin preparations on arterial smooth muscle cells: the role of contaminant platelet-derived growth factor. Libby P; Raines EW; Cullinane PM; Ross R J Cell Physiol; 1985 Dec; 125(3):357-66. PubMed ID: 2415538 [TBL] [Abstract][Full Text] [Related]
48. Adipogenic activities in commercial preparations of fetuin. Bachmeier M; Löffler G Horm Metab Res; 1994 Feb; 26(2):92-6. PubMed ID: 7515370 [TBL] [Abstract][Full Text] [Related]
50. Humoral factors in very young NZB mice that enhance the maturation of normal B cell precursors. Partial purification and characterization. Jyonouchi H; Kimmel MD; Lee G; Kincade PW; Good RA J Immunol; 1985 Sep; 135(3):1891-9. PubMed ID: 3926891 [TBL] [Abstract][Full Text] [Related]
51. 3T3 cells in adipocytic conversion. O'Shea Alvarez MS Arch Invest Med (Mex); 1991; 22(2):235-44. PubMed ID: 1726451 [TBL] [Abstract][Full Text] [Related]
52. Fetuin: its enigmatic property of growth promotion. Nie Z Am J Physiol; 1992 Sep; 263(3 Pt 1):C551-62. PubMed ID: 1384344 [TBL] [Abstract][Full Text] [Related]
53. Pedersen fetuin contains three adipogenic factors with distinct biochemical characteristics. Zaitsu H; Serrero G J Cell Physiol; 1990 Sep; 144(3):485-91. PubMed ID: 1697301 [TBL] [Abstract][Full Text] [Related]